Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction
- 25 January 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (3) , 3-11
- https://doi.org/10.1016/0002-9149(91)90082-v
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Guidelines for the early management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1990
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulationThe Lancet, 1990
- Unfractionated Heparin and CY 216: Pharmacokinetics and Bioavailabilities of the Antifactor Xa and IIa Effects after lntravenous and Subcutaneous Injection in the RabbitThrombosis and Haemostasis, 1989
- Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.Circulation, 1989
- Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarctionJournal of the American College of Cardiology, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Bioavailability and antagonization of the low molecular weight heparin CY 216 in manThrombosis Research, 1986
- Kinetics of intravenously administered heparin in normal humansBlood, 1982